January 27, 2023
International Business Times
Exclusive-EU May Pay More For Pfizer COVID Shots In Return For Lower Volume
Brussels is discussing with Pfizer and BioNTech the possibility of reducing the up to 500 million COV... See more »
Janssen: [Exclusive] Janssen, Illumina plan to reduce workforce in Korea
Janssen Korea and Illumina Korea are considering trimming their payroll, following the moves of other Korean offshoots of multinational pharmaceutical firms.According to industry sources, Janssen Korea is trying to reduce its workforce through an early retirement program (ERP)."I have heard that our
Read full article »
January 27, 2023
PR Newswire
Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Study unblinded following recommendation of Independent Data Monitoring Committee RARITAN, N.J., Jan.... See more »
January 27, 2023
Seeking Alpha
Novartis sees no benefit of Adakveo for sickle cell ailment in phase 3 trial
January 28, 2023Medthority
CHMP recommends darolutamide for the treatment of metastatic hormone-sensitive prostate cancer.- Bayer.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recomm... See more »
January 27, 2023NS Medical Devices
Roche rolls out Covid-19 PCR test to detect omicron sub-variant XBB.1.5
The post Roche rolls out Covid-19 PCR test to detect omicron sub-variant XBB.1.5 appeared first on NS... See more »
January 28, 2023Medthority
FDA appproves Keytruda for adjuvant treatment following surgical resection and chemotherapy for NSCLC.- Merck Inc.,
Merck Inc., known as MSD outside of the United States and Canada, announced that the FDA has approved... See more »
January 27, 2023Pharmabiz
WHO, Gilead Sciences extend collaborative pact to enhance access to treatment for visceral leishmaniasis
The World Health Organization (WHO) and Gilead Sciences have signed a new agreement for the donation ... See more »
January 27, 2023North American Windpower
GE Plans Nacelle, Blade Manufacturing Facilities
GE has submitted a plan to construct two new manufacturing facilities in New York if it wins a suffic... See more »
January 27, 2023MarketScreener
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
(marketscreener.com) By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines... See more »
January 27, 2023
International Business Times
Exclusive-EU May Pay More For Pfizer COVID Shots In Return For Lower Volume
Brussels is discussing with Pfizer and BioNTech the possibility of reducing the up to 500 million COV... See more »
January 27, 2023
PR Newswire
Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Study unblinded following recommendation of Independent Data Monitoring Committee RARITAN, N.J., Jan.... See more »
January 27, 2023
Seeking Alpha
Novartis sees no benefit of Adakveo for sickle cell ailment in phase 3 trial
January 28, 2023Medthority
CHMP recommends darolutamide for the treatment of metastatic hormone-sensitive prostate cancer.- Bayer.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recomm... See more »
January 27, 2023NS Medical Devices
Roche rolls out Covid-19 PCR test to detect omicron sub-variant XBB.1.5
The post Roche rolls out Covid-19 PCR test to detect omicron sub-variant XBB.1.5 appeared first on NS... See more »
January 28, 2023Medthority
FDA appproves Keytruda for adjuvant treatment following surgical resection and chemotherapy for NSCLC.- Merck Inc.,
Merck Inc., known as MSD outside of the United States and Canada, announced that the FDA has approved... See more »
January 27, 2023Pharmabiz
WHO, Gilead Sciences extend collaborative pact to enhance access to treatment for visceral leishmaniasis
The World Health Organization (WHO) and Gilead Sciences have signed a new agreement for the donation ... See more »
January 27, 2023North American Windpower
GE Plans Nacelle, Blade Manufacturing Facilities
GE has submitted a plan to construct two new manufacturing facilities in New York if it wins a suffic... See more »
January 27, 2023MarketScreener
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
(marketscreener.com) By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines... See more »
CEO
Tom Heyman
Janssen is a New Jersey-based pharmaceutical firm that researches and develops medicinal products for the treatment of oncology, cardiovascular and immunology.
Read more